Mechanism and prevention of aminoglycoside ototoxicity: Outer hair cells as targets and tools

Ear, Nose and Throat Journal

Volumn 76, Issue 3, 1997, Pages

  Priuska, Eric M ^a   Schacht, Jochen ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CHELATING AGENT; DEFEROXAMINE; FREE RADICAL; IRON COMPLEX; KANAMYCIN; PHOSPHATIDYLINOSITIDE; STREPTOMYCIN;

AGING; ARTICLE; GENETIC PREDISPOSITION; HAIR CELL; HUMAN; NONHUMAN; NUTRITION; OTOTOXICITY; RISK FACTOR;

EID: 0007412016     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556139707600310     Document Type: Article

References (52)

1. Schatz A, Bugie E, Waksman SA. Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. Proc Soc Exp Biol Med 1944; 55:66-9.
2. Hinshaw HC, Feldman WH. Streptomycin in treatment of clinical tuberculosis: A preliminary report. Proc Mayo Clinic 1945; 20:313-18.
3. Corrado AP. Respiratory depression due to antibiotics: calcium in treatment. J Intern Anest Res Soc 1963; 42:1-5.
4. Gordon S, Senson J, Facklam R, et al. NNIS Enterococcal Study Group. A multicenter study of the epidemiology of enterococcal infections (abstract). Program Abstr Intersci Co Antimicrob Agents Chemother 1989; 29:233.
5. Chiew YF, Lim SW, Kuah BG, et al. Prevalence in Singapore of enterococci with high-level resistance to aminoglycosides and comparison of three methods for their detection. J Infect 1993; 27:125-31.
6. Edson RS, Terrell CL. The Aminoglycosides. Proc Mayo Clinic 1991; 66:1158-64.
7. Lu YF. Cause of 611 deaf mutes in schools for deaf children in Shanghai. Shanghai Med J 1987; 10:159.
8. White Jr., GL, Henthorne BH, Barnes SE, et al. Tuberculosis: A health education imperative returns. J Community Health 1995; 20:29-57.
9. Whelton A. Therapeutic initiatives for the avoidance of aminoglycoside toxicity. J Clin Pharmacol 1985; 25:67-81.
10. Fee WE. Aminoglycoside ototoxicity in the human. Laryngoscope 1980; 40:1-19.
11. Gatell JM, San Miguel JG, Zamora L, et al. Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin. Antimicrob Agents Chemother 1983; 23:897-901.
12. Gatell JM, Ferran F, Araujo V, et al. Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides. Antimicrob Agents Chemother 1987; 31:1383-7.
13. Burton ME, Brater DC, Chen PS, et al. A Bayesian feedback method of aminoglycoside dosing. Clin Pharmacol Ther 1985; 37:349-57.
14. Rodvold KA, Blum RA. Predictive performance of Sawchuk-Zaske and Bayesian dosing methods for tobramycin. J Clin Pharmacol 1987; 27:419-24.
15. Begg EJ, Barclay ML, Duffull SB. A suggested approach to once-daily aminoglycoside dosing. Br J Clin Pharmacol 1995; 39:605-9.
16. Prazma J, Garrison HG, Williford SK, et al. Alteration of aminoglycoside antibiotic ototoxicity: Effect of semistarvation. Ann Otol Rhinol Laryngol 1983; 92:178-82.
17. Lautermann J, McLaren J, Schacht J. Glutathione protection against gentamicin ototoxicity depends on nutritional status. Hear Res 1995; 86:15-24.
18. Garetz SL, Altschuler RA, Schacht J. Attenuation of gentamicin ototoxicity by glutathione in the guinea pig in vivo. Hear Res 1994; 77:81-7.
19. Federspil P. Antibiotikaschäden des Ohres. Leipzig, Barth, 1979.
20. Prezant TR, Shohat M, Jaber L, et al. Biochemical characterization of a pedigree with mitochondrially inherited deafness. Am J Med Genet 1992; 44:465-72.
21. Forge A. Outer hair cell loss and supporting cell expenasion following chronic gentamicin treatment. Hear Res 1985; 19:171-82.
22. Forge A, Fradis M. Structural abnormalities in the stria vascularis following chronic gentamicin treatment. Hear Res 1985; 20:233-44.
23. Black FO, Pesznecker SC. Vestibular ototoxicity: Clinical considerations. Otolaryngol Clin North Am 1993; 26:713-36.
24. Warchol ME, Lambert PR, Goldstein BJ, et al. Regenerative proliferation in inner ear sensory epithelia from adult guinea pigs and humans. Science 1993; 259:1619-22.
25. Schacht J. Biochemical basis of aminoglycoside ototoxicity. Otolaryngol Clin North Am 1993; 26:845-56.
26. Garetz S, Schacht J. Ototoxicity: Of mice and men, in Fay RR, Popper AN (eds): Handbook of Auditory Research, Vol. VI: Clinical Aspects of Hearing (VanDeWater TR, ed). New York, Springer-Verlag, in press.
27. Tran Ba Huy P, Bernard P, Schacht J. Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. J Clin Invest 1986; 77:1492-1500.
28. Dulon D, Aran JM, Zajic G, et al. Comparative uptake of gentamicin, netilmicin, and amikacin in the guinea pig cochlea and vestibule. Antimicrob Agents Chemother 1986; 30:96-100.
29. Aran JM, Erre JP, Guilhaume A, et al. The comparative ototoxicities of gentamicin, tobramycin and dibekacin in the guinea pig. A functional and morphological cochlear and vestibular study. Acta Otolaryngol Suppl (Stockh) 1982; 390:1-30.
30. Henley CM, Schacht J. Pharmacokinetics of aminoglycoside antibiotics in blood, inner-ear fluids and tissues and their relationship to ototoxicity. Audiology 1988; 27:137-46.
31. Schacht J. Isolation of an aminoglycoside receptor from guinea pig inner ear tissues and kidney. Arch Otorhinolaryngol 1979; 224:129-34.
32. Richardson GP, Russell IJ. Cochlear cultures as a model system for studying aminoglycoside induced ototoxicity. Hear Res 1991; 53:293-311.
33. Brownell WE, Bader CR, Bertrand D, et al. Evoked mechanical responses of isolated cochlear outer hair cells. Science 1985; 227:194-6.
34. Zenner HP, Gitter A, Zimmermann U, et al. The isolated living hair cell - a new model to investigate hearing function. Laryngol Rhinol Otol 1985; 64:642-7.
35. Dulon D, Zajic G, Aran JM, et al. Aminoglycoside antibiotics impair calcium entry but not viability and motility in isolated cochlear outer hair cells. J Neurosci Res 1989; 24:338-46.
36. Williams SE, Zenner HP, Schacht J. Three molecular steps of aminoglycoside ototoxicity demonstrated in outer hair cells. Hear Res 1987; 30:11-8.
37. Huang MY, Schacht J. Formation of a cytotoxic metabolite from gentamicin by liver. Biochem Pharmacol 1990; 40: R11-4.
38. Crann SA, Huang MY, McLaren JD, et al. Formation of a toxic metabolite from gentamicin by a hepatic cytosolic fraction. Biochem Pharmacol 1992; 43:1835-9.
39. Schentag JJ, Jusko WJ. Renal clearance and tissue accumulation of gentamicin. Clin Pharmacol Ther 1977; 22:364-70.
40. Garetz S, Schacht J. Sulfhydryl compounds reduce gentamicin-induced outer hair cell damage in vitro. Assoc Res Otolarynogl 1992; 15:110.
41. Garetz SL, Rhee DJ, Schacht J. Sulfhydryl compounds and antioxidants inhibit cytotoxicity to outer hair cells of a gentamicin metabolite in vitro. Hear Res 1994; 77:75-80.
42. Zenner HP, Keiner S, Zimmerman U. Specific glutathione-SH inhibition of toxic effects of metabolized gentamicin on isolated guinea pig hair cells. Eur Arch Otorhinolaryngol 1994; 251:84-90.
43. Pierson MG, Miller AG. Prophylaxis of kanamycin-induced ototoxicity by a radioprotectant. Hear Res 1981; 7:79-87.
44. Bock GR, Yates GK, Miller JJ, et al. Effects of N-acetylcysteine on kanamycin ototoxicity in the guinea pig. Hear Res 1983; 9:255-62.
45. Darrouzet MJ. Attempt to protect the organ of Corti against the ototoxicity of antibiotics. Acta Otolaryngol (Stockh) 1967; 63 (Suppl):49-64.
46. Guo LH, Hill HA, Hopper DJ, et al. Direct voltammetry of the Chromatium vinosum enzyme, sulfide:cytochrome c oxidoreductase (flavocytochrome c552). J Biol Chem 1990; 265:1958-63.
47. Priuska EM, Schacht J. Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochemical Pharmacology 1995; 50:1749-52.
48. Wang H, Priuska EM, Schacht J. The iron embrace: Exposing the secret activities of gentamicin. Assoc Res Otolaryngol 1996; 19:29.
49. Sha SH, Schacht J. Amplification of free radicals by gentamicin in biological systems. Assoc Res Otolaryngol 1996; 19:30.
50. Song B-B, Schacht J. Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo. Hear Res 1996; 94:87-93.
51. Kanno H, Rybak LP, Whitworth C. The cochlear ototoxicity due to deferoxamine mesylate. Assoc Res Otolaryngol 1995; 18:76.
52. van Asbeck BS, Marcelis JH, van Kats JH, et al. Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin. Eur J Clin Microbiol 1983; 2:432-8.